
Scientists Call for Increased Limited Use of Antimicrobial Chemicals
More than 200 scientists, medical professionals, and environmental researchers have released a statement calling on the international community to take further steps to limit the use of triclosan, triclocarban, and other antimicrobial compounds.
Following a
Used in recent years in soaps, body washes, detergents and a host of other consumer products labeled as “antibacterial”,
In a recent
Among the list of reasons the statement’s authors want to see more limits on the use of triclosan and triclocarban are a lack of evidence on their effectiveness, evidence of their contribution to the problem of antibiotic resistance, evidence of their endocrine-disrupting effects on animals, detrimental effects on aquatic organisms, and their long-term persistence in the environment, where the antimicrobials are a source of toxic and carcinogenic compounds such as dioxin.
“Research shows that antimicrobials used as far back as the 1960s are still present in the environment, for example in freshwater and coastal sediments,” said Dr. Halden. Such persistence, note the authors in the statement, has made triclosan and its byproducts bioaccumulate in the environment. They also appear in human blood and breast milk. “Completely cleansing the planet from antimicrobials used in the past will take several decades at a minimum and potentially much longer than that.”
As the authors call on scientists, governments, chemical and product manufacturers, purchasing organizations, retailers, and consumers to avoid the use of triclosan and triclocarban, they offer a framework for moving forward with these and other antibacterial ingredients. “Because antimicrobials can have unintended adverse health and environmental impacts, they should only be used when they provide an evidence-based health benefit,” the authors write. “Greater transparency is needed in product formulations, and before an antimicrobial is incorporated into a product, the long-term health and ecological impacts should be evaluated.”
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.